Azathioprine or 6-mercaptopurine for maintaining remission in Crohn's disease
42 results
1 - 42
Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease- Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease
- Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease
- Adalimumab for maintenance of remission in Crohn's disease
- Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease
- Enteral nutrition for maintenance of remission in Crohn's disease
- Methotrexate for maintenance of remission in Crohn's disease
- Infliximab for maintenance of medically‐induced remission in Crohn's disease
- Methotrexate for maintenance of remission in ulcerative colitis
- Budesonide for maintenance of remission in Crohn's disease
- Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease
- Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease
- Anti‐tuberculous therapy for maintenance of remission in Crohn's disease
- Vedolizumab for induction and maintenance of remission in Crohn's disease
- Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
- Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
- Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
- Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
- Glutamine for induction of remission in Crohn's disease
- Antibiotics for induction and maintenance of remission in Crohn's disease
- Corticosteroids for maintenance of remission in Crohn's disease
- Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease
- Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
- Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease